IP Library › Granted Patent US 11,172,984
Granted Patent B2
US 11,172,984 · App. 16/864,704 · Granted Nov 16, 2021

Device, system and method to ablate cardiac tissue

Inventors: Reecha Sharma (Irvine, CA); Robert B. Stagg (Irvine, CA); Zhong Wang (Irvine, CA); Betzi Zafra (Irvine, CA); Lee Ming Boo (Irvine, CA); Assaf Govari (Haifa, IL); Thomas V. Selkee (Irvine, CA); Christopher Thomas Beeckler (Brea, CA); Andres Claudio Altmann (Irvine, CA); Joseph Thomas Keyes (Sierra Madre, CA); Athanassios Papaioannou (Irvine, CA); Kristine B. Fuimaono (Irvine, CA)
Assignee: BIOSENSE WEBSTER (ISRAEL) LTD.
A61B18/1492A61B2018/00351A61B2018/00577A61B2018/00678A61B2018/00714A61B2018/00755A61B2218/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,172,984
App. No.
16/864,704
Granted
Nov 16, 2021
Kind
B2
Abstract

A method that includes selectively positioning an ablation catheter system at a treatment site; and ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90 W applied to tissue for approximately four (4) second increments with a break period of approximately 4 seconds between applications.

Claims (14)

1. A method or use, comprising:

selectively positioning an ablation catheter system at a treatment site;

ablating tissue at the treatment site with the ablation catheter system using a power setting of approximately 90 W applied to tissue for a first ablation time of approximately four (4) seconds to achieve a first maximum tissue temperature;

ceasing ablation for a break period of approximately 4 seconds immediately following the first ablation time; and

ablating, immediately after the break period of approximately 4 seconds and using the power setting of approximately 90 W applied to the tissue for a second ablation time of approximately 4 seconds, the tissue at the treatment site with the ablation catheter system to achieve a second maximum tissue temperature.

2. The method or use of claim 1 , wherein the second maximum tissue temperature is approximately 76° C.

3. The method or use of claim 1 , the step of ablating tissue further comprising increasing of temperature between first and second maximum tissue temperature by at least about 13% between first and second ablation applications.

4. The method or use of claim 1 , the step of ablating tissue comprises a point-by-point “kissing” ablation approach causing a continuous and transmural linear lesion line at the atrial wall with minimal over-lapped lesions.

5. The method or use of claim 1 , the step of ablating tissue comprising achieving a lesion depth approximately 40% deeper between first and second ablation applications, the method or use further comprising applying to the treatment site, by a distal end of the ablation catheter system, a contact force ranging between approximately 5-30 grams.

6. The method or use of claim 1 , further comprising:

delivering, by and through an elongated body of the ablation catheter system, a continuous infusion of approximately 8 milliliters/minute of treatment solution when not delivering radiofrequency energy during radiofrequency ablation.

7. The method or use of claim 1 , further comprising:

moving the ablation catheter system approximately 4 millimeter if clinically effective ablation is achieved within 20 seconds as determined by electrogram reduction and/or impedance drop.

8. The method or use of claim 1 , wherein the first maximum tissue temperature is approximately 67.5° C. and the second maximum tissue temperature is approximately 76.3° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2020
From: SHARMA, REECHA; STAGG, ROBERT B.; WANG, ZHONG; ZAFRA, BETZI; BOO, LEE MING; GOVARI, ASSAF; SELKEE, THOMAS V.; BEECKLER, CHRISTOPHER THOMAS; ALTMANN, ANDRES CLAUDIO; KEYES, JOPSEH THOMAS; PAPAIOANNOU, ATHANASSIOS; FUIMAONO, KRISTINE B.
To: BIOSENSE WEBSTER (ISRAEL) LTD.
Reel/Frame 052550/0249 →
Continuity (3)
Provisional Application 62843213 · May 3, 2019
Provisional Application 62892464 · Aug 27, 2019
Related Publication 20200345415A1 · Nov 5, 2020
Cited By (4)
US 12,213,727 US 12,213,728 US 12,357,365 US 12,708,431